Stocktoria
LEMAITRE VASCULAR INC LMAT
LEMAITRE VASCULAR INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M | $129.4M | $117.2M | $105.6M | $100.9M | $89.2M |
| Gross profit | $178.5M | $150.9M | $127.0M | $104.9M | $101.4M | $84.6M | $79.9M | $73.9M | $70.7M | $62.9M |
| R&D expense | $14.1M | $15.7M | $17.0M | $13.3M | $11.8M | $10.1M | $9.3M | $8.2M | $6.6M | $6.1M |
| Operating income | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M | $28.8M | $21.2M | $28.2M | $21.1M | $16.3M |
| Interest expense | $5.2M | $205,000 | $0 | $0 | $2.2M | $1.3M | $0 | $2,000 | $21,000 | $14,000 |
| Income tax | $17.4M | $12.8M | $9.4M | $6.9M | $7.4M | $6.1M | $3.7M | $5.5M | $3.9M | $5.7M |
| Net income | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M | $21.2M | $17.9M | $22.9M | $17.2M | $10.6M |
| EPS (diluted) | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 | $0.88 | $1.13 | $0.86 | $0.55 |
| Operating cash flow | $81.3M | $44.1M | $36.8M | $25.4M | $35.1M | $34.8M | $14.2M | $19.5M | $22.9M | $16.9M |
| Free cash flow | — | — | — | — | — | — | — | — | — | $14.1M |
| Cash & equivalents | $28.2M | $25.6M | $24.3M | $19.1M | $13.9M | $26.8M | $11.8M | $26.3M | $19.1M | $24.3M |
| Inventory | — | — | — | — | — | — | — | — | — | $19.6M |
| Total assets | $615.7M | $551.8M | $346.8M | $310.5M | $292.8M | $252.8M | $188.3M | $153.1M | $126.3M | $101.9M |
| Total liabilities | $222.2M | $214.5M | $48.9M | $42.3M | $38.7M | $80.2M | $40.2M | $22.9M | $16.6M | $14.4M |
| Shareholders' equity | $393.5M | $337.3M | $297.9M | $268.2M | $254.2M | $172.6M | $148.1M | $130.2M | $109.8M | $87.5M |
Growth · year-over-year · Revenue CAGR 12.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +13.5% | +13.6% | +19.7% | +4.7% | +19.4% | +10.4% | +11.0% | +4.7% | +13.1% | +13.8% |
| Net income growth | +31.1% | +46.3% | +45.9% | -23.3% | +26.8% | +18.3% | -21.8% | +33.6% | +62.2% | +36.5% |
| EPS growth | +30.6% | +44.0% | +44.1% | -25.6% | +20.2% | +18.2% | -22.1% | +31.4% | +56.4% | +31.0% |
| Free cash flow growth | — | — | — | — | — | — | — | — | — | +53.4% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.